Recipharm Pharmaservices Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Khata No. 845/713 and 1108/970/1, 34th KM, Tumkur Road, (NH 4) Teppada Begur, Nelamangala Taluk, Bengaluru, KA 562123, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3009150119 · DUNS 871401927
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2024-03-22
- VAIDrug Quality Assurance2020-02-13
- VAIDrug Quality Assurance2019-02-01
- NAIDrug Quality Assurance2018-05-11
- NAIDrug Quality Assurance2015-03-19
- VAIDrug Quality Assurance2012-11-01
Drugs this plant is listed as making
7 distinct drugs across 15 products name this site in their FDA label.
- atorvastatin calciumBiocon Pharma Inc.
- Bedaquiline FumarateJanssen Products, LP
- Doxylamine succinate and Pyridoxine hydrochlorideBionpharma Inc.,
- etravirineBionpharma Inc.
- loperamide hydrochlorideBionpharma Inc.
- Rosuvastatin calciumBiocon Pharma Inc
- TheophyllineBionpharma Inc.,
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.